A High-Throughput Screen for Tuberculosis Progression
2011

High-Throughput Screening for Tuberculosis Progression Using Zebrafish

Sample size: 2000 publication 10 minutes Evidence: high

Author Information

Author(s): Ralph Carvalho, Jan de Sonneville, Oliver W. Stockhammer, Nigel D. L. Savage, Wouter J. Veneman, Tom H. M. Ottenhoff, Ron P. Dirks, Annemarie H. Meijer, Herman P. Spaink

Primary Institution: ZF-screens B.V., Leiden, The Netherlands

Hypothesis

Can a high-throughput screening system using zebrafish effectively model tuberculosis progression and test anti-tuberculosis compounds?

Conclusion

The developed high-throughput system using zebrafish can effectively model tuberculosis progression and test the efficacy of anti-tuberculosis drugs.

Supporting Evidence

  • The zebrafish model mimics human tuberculosis pathology, allowing for effective drug testing.
  • The automatic injector achieved a throughput of 2,000 embryos per hour.
  • Zebrafish larvae showed similar disease symptoms to those observed in human tuberculosis.
  • Drug treatment significantly reduced bacterial load in treated zebrafish compared to untreated ones.

Takeaway

Researchers created a new way to study tuberculosis using tiny fish called zebrafish, which helps them test new medicines quickly and easily.

Methodology

The study involved developing an automatic injection system for zebrafish embryos to test the progression of tuberculosis and the efficacy of drugs.

Limitations

The study primarily focuses on the zebrafish model, which may not fully replicate human tuberculosis pathology.

Participant Demographics

Zebrafish embryos were used as the model organism.

Statistical Information

P-Value

0.0004

Statistical Significance

p=0.0004

Digital Object Identifier (DOI)

10.1371/journal.pone.0016779

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication